« Previous
Next »
Nuclear Medicine and Biology
Volume 33, Issue 1
, Pages 65-70
, January 2006
Animal-specific positioning molds for registration of repeat imaging studies: comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors
References
- . PET scanners dedicated to molecular imaging of small animal models. Mol Imaging Biol. 2002;4:47–63
- . Micro-PET imaging and small animal models of disease. Curr Opin Immunol. 2003;15:378–384
- . The biological application of small animal PET imaging. Nucl Med Biol. 2001;28:585–593
- . Small-animal PET: advent of a new era of PET research. J Nucl Med. 1999;40:1176–1179
- . Positron emission tomography: a review of basic principles, scanner design and performance, and current systems. Semin Nucl Med. 2004;34:87–111
- A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography. Med Phys. 2003;30:2303–2314
- . Software for image registration: algorithms, accuracy, efficacy. Semin Nucl Med. 2003;33:180–192
- . Image registration: an essential tool for nuclear medicine. Eur J Nucl Med Mol Imaging. 2002;29:559–577
- . Image registration by maximization of combined mutual information and gradient information. IEEE Trans Med Imaging. 2000;19:809–814
- . Mutual-information-based registration of medical images: a survey. IEEE Trans Med Imaging. 2003;22:986–1004
- . Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging. 1997;16:187–198
- . Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol. 1998;46:229–237
- . On measuring mypoxia in individual tumors with radiolabeled agents. J Nucl Med. 2001;42:1653–1655
- Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys. 1996;36:417–428
- . Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys. 1989;17:985–991
- . Rapid synthesis of 3-[18F]fluoro-1-2-(2′-nitro-imidazolyl)-2-propranol([18F]fluoromisonidazole). Pharm Res. 1994;11:466–469
- Performance evaluation of microPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging. J Nucl Med. 1999;40:1164–1175
- MicroPET: a high resolution PET scanner for imaging small animals. IEEE Trans Nucl Sci. 1997;NS-44:1161–1166
- Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. Int J Radiat Oncol Biol Phys. 2005;61:1493–1502
- A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia. Eur J Nucl Med Mol Imaging. 2004;31:1530–1538
- Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning. Eur J Nucl Med Mol Imaging. 2004;31:117–128
- . Clinical PET in oncology. Clin Positron Imaging. 1998;1:15–30
- PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol. 2003;30:1419–1437
- . Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography-a study evaluating [18F]fluoro-2-deoxy-d-glucose. Acta Oncol. 2000;39:629–637
- . Hypoxia-induced increase in FDG uptake in MCF7 cells. J Nucl Med. 2001;42:170–175
- . Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 1995;36:1625–1632
- Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin Cancer Res. 2004;10:2245–2252
- [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging. 2003;30:695–704
PII: S0969-8051(05)00199-X
doi: 10.1016/j.nucmedbio.2005.07.011
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Nuclear Medicine and Biology
Volume 33, Issue 1
, Pages 65-70
, January 2006
